Steven Bourke

Steven Bourke has a strong background in market access and strategic market access roles within the pharmaceutical and healthcare industry. Steven is currently serving as the Vice President of Market Access at ADC Therapeutics since 2022. Prior to that, they worked as the VP of Strategic Market Access, Oncology at Novartis from 2021 to 2022. Steven has also held executive positions at Novartis Oncology, serving as the Executive Director of National Accounts from 2018 to 2021 and as the Director of Strategic Market Access, Oncology from 2015 to 2018. Before joining Novartis, they worked at Veloxis Pharmaceuticals as the Head of Market Access from 2014 to 2015. Steven gained experience in market access strategy and patient services at Ipsen, where they served as the Sr Director of Market Access Strategy and Patient Services from 2013 to 2014 and as the Director of Reimbursement and Patient Services from 2012 to 2014. Steven also served as the Manager of Patient Support and Reimbursement Services at Celgene from 2009 to 2012. Steven started their career as a Pharmacist in Charge at CVS/Caremark from 2005 to 2009 and as a Pharmacy Manager/Pharmacist Coordinator at Eckerd from 1999 to 2005.

Steven Bourke attended Western New England University from 1996 to 1999, where they pursued pre-pharmacy studies. Following that, they attended the Massachusetts College of Pharmacy and Health Sciences from 1996 to 2001, earning a Bachelor of Science degree in Pharmacy.